Single Increasing Doses of BIII 890 CL in Healthy Young Male Volunteers and in Healthy Elderly Male and Female Volunteers
Clinical trial NCT02269215 · COMPLETED
Trial details
- NCT number
- NCT02269215
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2000-01-01
- Primary completion
- 2000-09-01
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.